ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
Nature Medicine2017Vol. 23(12), pp. 1405–1415
Citations Over TimeTop 10% of 2017 papers
David Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, Alba Santos, Clemens K. Probst, Alicia Franklin, Daniela M. Santos, Paula Grasberger, Neil Ahluwalia, Sydney B. Montesi, Barry S. Shea, Katharine E. Black, Rachel S. Knipe, Meryem Blati, Murray Baron, Brian Wu, Hassan Fahmi, Rajiv Gandhi, Annie Pardo, Moisés Selman, Jiangping Wu, Jean‐Pierre Pelletier, Johanne Martel‐Pelletier, Andrew M. Tager, Mohit Kapoor
Related Papers
- → The ADAM10 Prodomain Is a Specific Inhibitor of ADAM10 Proteolytic Activity and Inhibits Cellular Shedding Events(2007)146 cited
- → A disintegrin and metalloproteinase (ADAM)‐mediated ectodomain shedding of ADAM10(2009)68 cited
- → Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-α(2009)56 cited
- → The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition(2008)43 cited
- → A Disintegrin And Metalloprotease Adam10 Controls Endothelial Functions In Atherosclerosis(2019)